Acute graft versus host disease
Not recruitingStudy on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease
Study on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease
- Disease:Acute graft versus host disease
- Substances:Allogeneic Mesenchymoangioblast-Derived Mesenchymal Stem Cells
France- Participants:18–64 years · 65+ years
- Substances:Allogeneic Mesenchymoangioblast-Derived Mesenchymal Stem Cells
- Sponsor:Cynata Therapeutics Limited






